Silica Reinforcing Filler: How It Strengthens Rubber and Polymers

Published: Source: Silica Raw Materials News Section: Silica Raw Materials

📌 Key Takeaways

  • Topic: Submicron Spherical Silica: Specifications and Uses in Underfill and Advanced Packaging
  • Keywords: quartz sand for photovoltaic
  • Published: 2026-11-20 11:38:37
  • Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
In the case of melt granulation, it is necessary to use meltable excipients that can melt at low temperatures (50-90 °C) as a binder [ 98, 108 ]. The molten binder forms the agglomerates during cooling and solidification. Since it does not need a liquid binder, it is advantageous for use in the case of moisture-sensitive molecules. However, its use should be avoided for heat-sensitive materials.

Precipitated Silica Market 2026: Size, Tire Demand and Growth Forecast

HDK N20: Specifications, Applications and Equivalent Grades
Silica Aerogel Powder: Properties, Applications and How It Compares to Other Insulators
Nanocarriers can be divided into two principal groups: organic and inorganic types. The organic group contains lipid nanocarriers, liposomes, polymeric nanoparticles, dendrimers, etc. In the case of the carriers in this group, the limited volume of delivered active pharmaceutical ingredient (API) is a clear disadvantage, along with decreased stability, and good sensitivity to temperature, pH, and enzymes in a physiological environment. The inorganic group contains metal oxide-, carbon-, silicon-, silica-, and quantum dot-based nanocarriers. Their benefits are greater stability and well-tunable physicochemical properties, but their accumulation in the body may be a key question of their applicability. Silica nanoparticles (SNP) are silicon dioxide (SiO 2 ) nanoparticles in an amorphous state and have excellent potential in the pharmaceutical industry and drug development due to their special properties. According to pore size, the most common, most well-liked, and most effective type of silica nanocarriers are the mesoporous silica nanoparticles (MSNs) [ 1 ].
Silica Free Flow Agent: Typical Dosage, Benefits and Best Grades
Nano Silica Supplier: How to Verify Particle Size, Purity and Consistency
Certain molecules have an excessive adhesive property, and this represents another problem to be eliminated during direct tableting. In this case, a tiny amount of powder adheres to the surface of the upper- and lower punch or the die during each compression cycle [ 94 ]. Therefore, tablet weight changes, and tablets with an uneven surface are obtained. More importantly, this may bring about poor content uniformity due to API loss. By contrast, if the greatly adhesive API is enclosed in the pores of the silica carrier, direct contact with the metal parts is eliminated. Thus, the loss of the API can be avoided [ 92, 94 ].

Microsilica for Cement: Benefits, Dosage Guidelines and Applications

What is silica (SiO₂)?

silica refractive index 49. Dwyer L.M., Michaelis V.K., O'Mahony M., Griffin R.G., Myerson A.S. Confined crystallization of fenofibrate in nanoporous silica. CrystEngComm. 2015;17:7922-7929. doi: 10.1039/C5CE01148E. [ DOI ] [ PMC free post ] [ PubMed ] [ Google Scholar ]

What is the difference between fumed silica and precipitated silica?

silica for printing ink

What drives silica raw material prices?

silicosis MSNs are SiO 2 nanoparticles [ 2 ] with a pore diameter between 2 and 50 nm [ 3, 4 ] and with a total diameter of a maximum of 1 µm. Their use in drug delivery dates to the early 1990s when they were synthesized for various scientific applications [ 5 ]. The material known as mesoporous silica was discovered by Mobil Oil Corporation in 1992 [ 6 ]. Their first drug delivery application was demonstrated in 2001 when MCM-41 silica was used to release ibuprofen [ 7 ]. Since then, MSNs have become an increasingly popular drug delivery system due to their advantageous properties and have been typically recognized as secure (GRAS) by the FDA. Tiny SNPs have been approved for human clinical imaging studies, setting the stage for their use in clinical applications of drug delivery. The number of related research activities is continuously increasing each year, expanding their role in cancer treatment, gene delivery, and oral illness therapy [ 5 ]. Their pore size is located between microporous and macroporous systems. They can be used in diverse shapes (sphere, cube, ellipsoid, rod) and sizes, with different pore sizes and pore structures [ 2, 3, 4, 8, 9, 10 ]. They have a high degree of stability [ 8 ] and a rigid framework, which results in resistance to temperature, pH, enzymatic degradation, and mechanical force [ 4 ]. Thanks to the large number of pores, they have a massive particular surface region (approx. 700-1300 m 2 /g) and pore volume (approx. 0.5-1.5 cm 3 /g), which enables effective adsorption of diverse molecules [ 2, 3, 4, 8, 9, 10 ]. By changing the pore size distribution, the range of adsorbable molecules can be controlled [ 3 ], which also lets separation based on size exclusion, which means selective adsorption of molecules of certain sizes. Depending on the size of the pores, tiny molecules together with high molecular weight proteins can be transported into the pores [ 8 ]. In addition, chemical separation is also possible if the surface of the pores is coated with specific functional groups [ 4 ], which enables the separation of the APIs according to their structure [ 4 ]. Such modifications may include the setting of hydrophilicity/hydrophobicity of the surface, depending on whether the adsorption of hydrophobic or hydrophilic molecules is targeted [ 4 ]. By inserting different functional groups, the surface charge can also be controlled so that certain molecules will bind more efficiently. MSNs have a negative surface charge in biological environments, which promotes the electrostatic adsorption of positively charged APIs in the pores [ 10 ]. Moreover, the biological markers attached to the surface of the nanoparticles enable the drug-carrying system to deliver the API in a tissue-specific manner [ 2, 4, 8, 9, 10 ]. A substantial problem is the premature release of the API from the pores during transport [ 4, 8 ], which can be solved by utilizing gatekeepers that respond to special stimuli and keep the pores closed until the stimulus [ 2, 4, 8 ]. In this way, controlled drug delivery and stimuli-responsive release can be achieved [ 2, 4, 9 ]. The drug release could be triggered by temperature, pH, redox potential, light, enzymes, magnetic field, or different ligands [ 4, 8, 11 ].

Cite this article: Silica Raw Materials News. "Pharmaceutical Grade Silica: Specifications, USP/EP Standards and Uses as an Excipient ." Published 2026-11-20 11:38:37. /news/article.html
Disclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.